UR Medicine Faculty
The University of Rochester Medical Faculty Group
(URMFG) consists of over 900 specialist and primary care providers spanning 19
departments.
URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner
Accountable Health Partners (AHP) is a network of
over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the
region. AHP offers a full range of care.
Chad Heatwole, MD, MS-CI is a Professor of Neurology and the Director of the Center for Health and Technology at the University of Rochester Medical Center. He has an engineering degree from Virginia Tech, a medical degree from the Medical College of Virginia, a master's degree in clinical investiga...
Chad Heatwole, MD, MS-CI is a Professor of Neurology and the Director of the Center for Health and Technology at the University of Rochester Medical Center. He has an engineering degree from Virginia Tech, a medical degree from the Medical College of Virginia, a master's degree in clinical investigation, and he has completed a University of Rochester neurology residency, electrophysiology fellowship, and NIH-funded neuromuscular experimental therapeutics fellowship. He has had continuous grant funding over the last 17 years and has served as the Principal Investigator on dozens of research grants, including awards from the National Institutes of Health (NIH), Muscular Dystrophy Foundation, New York State, and numerous research foundations. Dr. Heatwole's research has led to the development of an internationally recognized network dedicated to improving the quality-of-life of patients with neuromuscular diseases through patient-centered clinical research, therapeutic development, and the discovery of a novel therapeutic approach for patients with muscular dystrophy. His professional interests include providing optimal care to patients with neuromuscular disorders, conducting electrodiagnostic studies, training medical personnel, developing novel experimental therapeutics for neurological diseases though clinical trials, and developing and validating disease-specific, patient-relevant endpoint measures for use in clinical trials and patient monitoring.
Faculty Appointments
Professor
-
Department of Neurology, Center for Health and Technology (SMD)
Director
-
Center for Health and Technology
Credentials
Residency & Fellowship
Fellowship, Clinical Neurophysiology, University of Rochester Medical Center. 2005 - 2006
Residency, Neurology, University of Rochester Medical Center. 2002 - 2005
Internship, University of Rochester Medical Center. 2001 - 2002
Education
MD | Virginia Commonwealth University Medical School.2001
Awards
University of Rochester Master Mentors Program..2016
Myotonic Dystrophy Foundation (MDF) Travel Award to Facilitate Myotonic Dystrophy Health Index (MDHI) Translational Research.2015
Chairman of Patient Reported Outcome Measures for Myotonic Dystrophy; OMMYD Meeting.2013
Chairman of DM1 Clinical Trials & Biomarkers Session. IDMC-.2013
Chairman of Ethical-Legal-Social Issues in Myotonic Dystrophy Session. IDMC-9.2013
Myotonic Dystrophy Foundation Research Grant (Supervising Mentor for Dr. Nick Johnson).2012 - 2014
FDA Research Grant: Mexiletine Treatment in Myotonic Dystrophy Type-1 (Co-Investigator).2011 - 2015
Clinical Research Loan Repayment Grant Renewal Recipient.2010
NIH Clinical Research Loan REpayment Grant REnewal Recipient.2010 - 2012
NIH Clinical Research Loan Repayment Grant Recipient.2008 - 2010
Clinical Research Loan Repayment Grant Renewal Recipient.2008
Paul Wellstone Muscular Dystrophy Cooperative Research Center Umbrella Center.2008
2008 Muscular Dystrophy Association Translational Research Infrastructure Grant Award Winner (Funding from 2008-2011).2008 - 2011
ECRIP (Empire Clinical Research Investigator Program) Grant Award Winner (.2008 - 2010
NIH K23 Career Development Grant Award Winner (NIAMS).2008 - 2013
NIH Clinical and Translational Science Institute K12 Award Recipient.2007
NIH Clinical Research Loan Repayment Grant Recipient.2006 - 2008
NIH Experimental Therapeutics Grant Recipient for.2006 - 2007
Ad Hoc editor for Neurology.2005
American Neurology Association Scholarship Winner, Toronto 2004.2004
UCB Pharma, Inc. Neurology Resident Scholar.2003
UCB Pharma, Inc. Neurology Resident Scholar. 2003.2003
Student Elective Term Scholarship Winner (MMA) 1999.1999
S.O.M. State Discretionary Scholarship Winner.1998 - 1999
S.O.M. State Discretionary Scholarship Winner 1998, 1999.1998 - 1999
Awarded Virginia Tech's Best ESM 1997 Ind. Senior Project Presentation.1997
Student Elective Term Scholarship Winner (MMA) 1999.
Awarded Virginia Tech's Best ESM Ind. Senior Project Presentation 1997.
Tau Beta Pi National Engineering Honor Society.
Golden Key Member.
Dean's List (General Engineering, and in ESM).
Board of Supervisors Academic Excellence Award.
American Neurology Association Scholarship Winner 2004.
Tau Beta Pi National Engineering Honor Society.
Golden Key Member.
Dean's List (General Engineering, and in ESM).
Board of Supervisors Academic Excellence Award.
Patient and Family-Centered Care award (2011).
Patient and Family Centered Care Award.
Strong Star Award for Exceptional Service and Displaying Compassion and Respect to Patients, Families and Co-workers.
Recognized by 2019 medical student survey as one of the University of Rochester's Inspiring Faculty Members.
Muscle and Nerve award for authorship of one of the most read/viewed manuscripts in 2018-2019.
Research
Dr. Heatwole’s research laboratory is internationally known for therapeutics research and the development, validation, and analysis of highly sensitive patient-relevant outcome measures for use in drug labeling trials. Dr. Heatwole has designed and implemented numerous investigator-initiated clinica...
Dr. Heatwole’s research laboratory is internationally known for therapeutics research and the development, validation, and analysis of highly sensitive patient-relevant outcome measures for use in drug labeling trials. Dr. Heatwole has designed and implemented numerous investigator-initiated clinical studies and has developed more than 100 disease-specific instruments. These instruments are extensively used globally to measure therapeutic gain during clinical trials and have been used in academic initiated trials, pharmaceutic sponsored trials, government initiated trials, and as clinical markers of disease burden. Through his joint role as Director of the Center for Health and Technology and Director/Founder of the Outcomes Division at the Center for Health and Technology, Dr. Heatwole facilitates the study, development, evaluation, and approval of promising human therapeutics. Diseases that he is currently focusing on include:
Dr. Heatwole is fully committed to the study and development of novel experimental therapeutics. He has planned, conducted, and analyzed numerous clinical studies including ones involving mexiletine, recombinant human insulin-like growth factor, antisense oligonucleotides, and novel endocrine based approaches.
Dr. Heatwole’s other research initiatives seek to better understand the baseline abnormalities associated with neuromuscular disease, understand the association between biomarkers and disease severity, and predict how muscular dystrophies progress over time. This work has led to the identification of defining laboratory characteristics in muscular dystrophies, data on the disease progression in FSHD and myotonic dystrophy, outcome measure development, biomarker discovery, evidence-based guidelines, and a novel differentiating clinical sign for myotonic dystrophy type-1 and type-2.
Trucco F, Salmin F, Lizio A, Coratti G, Albamonte E, Frisoni MC, Mauro L, Carraro E, Palazzo G, Lops J, Cattaneo C, Pozzi S, Casiraghi J, Di Bari A, Berti B, Stanca G, Ricci M, Pane M, Heatwole C, Dilek N, Mercuri E, Sansone VA
Dysphagia.. 2023 December 38 (6):1568-1580. Epub 06/08/2023.
Sansone VA, Pirola A, Lizio A, Greco LC, Coratti G, Casiraghi J, Pane M, Pera MC, Italiano C, Messina S, Pozzi S, Sframeli M, D'Amico A, Bertini E, Bruno C, Mauro L, Salmin F, Stancanelli C, Pedemonte M, Albamonte E, Zizzi C, Heatwole C, Mercuri E,
Neuromuscular disorders : NMD.. 2021 May 31 (5):409-418. Epub 02/09/2021.
Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Ströbel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJGM, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Silvestri NJ, Conwit R, Sonett JR, Jaretzki A, Newsom-Davis J, Cutter GR,
The Lancet. Neurology.. 2019 March 18 (3):259-268. Epub 01/25/2019.
Consensus-based Care Recommendations for Adults with Myotonic Dystrophy Type 2.
Benedikt Schoser; Federica Montagnese; Guillaume Bassez; Barbara Fossati; Josep Gamez; Chad Heatwole; James Hilbert; Cornelia Kornblum; Anne Kostera-Pruszczyk; Ralf Krahe; Anna Lusakowska; Giovanni Meola; Richard Moxley; Charles Thornton; Bjarne Udd; Paul Formaker.
Neurology: Clinical Practice. [In print]. 2019; .
Limb?Girdle Muscular Dystrophy: A perspective from adult patients on what matters most.
Hunter M, Heatwole C, Wicklund M, Weihl CC, Mozaffar T, Statland JM, Johnson NE.
Muscle & Nerve. 2019; .
Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).
Johanna Hamel, Nicholas E. Johnson, Rabi Tawil, William B. Martens, Nuran Dilek, Michael P. McDermott, and Chad Rydel Heatwole.
Heatwole C, Bode R, Nicholas Johnson , Dekdebrun J, Dilek N, Eichinger K, Hilbert JE, Logigian E, Luebbe E, Martens W, McDermott MP, Pandya S, Puwanant A, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT
Muscle & nerve.. 2016 February 53 (2):183-90. Epub 12/29/2015.
Heatwole C, Johnson N, Bode R, Dekdebrun J, Dilek N, Hilbert JE, Luebbe E, Martens W, McDermott MP, Quinn C, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT
Neurology.. 2015 December 1585 (24):2136-46. Epub 11/18/2015.
Bann CM, Abresch RT, Biesecker B, Conway KC, Heatwole C, Peay H, Scal P, Strober J, Uzark K, Wolff J, Margolis M, Blackwell A, Street N, Montesanti A, Bolen J
Neurology.. 2015 March 1084 (10):1034-42. Epub 02/06/2015.
Bushby K, Finkel R, Wong B, Barohn R, Campbell C, Comi GP, Connolly AM, Day JW, Flanigan KM, Goemans N, Jones KJ, Mercuri E, Quinlivan R, Renfroe JB, Russman B, Ryan MM, Tulinius M, Voit T, Moore SA, Lee Sweeney H, Abresch RT, Coleman KL, Eagle M, Florence J, Gappmaier E, Glanzman AM, Henricson E, Barth J, Elfring GL, Reha A, Spiegel RJ, O'donnell MW, Peltz SW, Mcdonald CM,
Heatwole C, Bode R, Johnson N, Dekdebrun J, Dilek N, Heatwole M, Hilbert JE, Luebbe E, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley R
Neurology.. 2005 March 2264 (6):1096-7. Epub 1900 01 01.
Books
Swaiman's Pediatric Neurology Principles and Practice Sixth Edition
(2017)
Chapter: Channelopathies: Myotonic Disorders and Periodic Paralysis
Authors: Heatwole, C; Moxley, R.
Publisher:
Elsevier 2017
AANEM
(2014)
Chapter: Myotonic Dystrophy Health Index: Initial Evaluation of a Disease-Specific Outcome Measure
Authors: Heatwole, C
Publisher:
AANEM podcast 2014
Swaiman's Pediatric Principles and Practice 5th edition
(2012)
Chapter: Channelopathies: Myotonic Disorders and Periodic Paralysis
Authors: Heatwole, C; Moxley, R.
Publisher:
Elsevier Saunders 2012
Neuromuscular Disorders
(2011)
Chapter: Myotonic Dystrophies
Authors: Johnson, N; Heatwole, C
Publisher:
Blackwell Publishing Ltd 2011
The Corridor
(2009)
Authors: C.R. Heatwole
Publisher:
James A Rock & Co. Publishers 2009
Principles of Drug Therapy in Neurology
(2008)
Chapter: Pharmacologic Treatment of Neuromuscular Disease
Authors: Chad R. Heatwole, MD; Richard T. Moxley III, MD
Publisher:
F.A. Davis 2008
Minimizing the Spread of Infectious Disease Through Lavatory Design.
(2007)
Authors: Heatwole, CR; Heatwole, CM; Heatwole, EE; Potts, EE
Publisher:
Engineering Design and Construction 2007
Land of Beauty and Hardship: SET in Nepal
(2005)
Authors: Heatwole, CR.
Publisher:
The Mennonite Health Journal. 7:3 2005
SET Training in the Land of Mt. Everest.
(2002)
Authors: Heatwole, CR.
Publisher:
The Mennonite Health Journal 4:1 2002
Ratings & Comments
At URMC, we believe that patients should be empowered to make the right decisions regarding their
personal
healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all
aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying
star ratings for our providers along with anonymous patient comments on our website. This will help you make
better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used
to generate this vital information. Learn more about
our survey process.
Ratings
Concern the care provider showed for your questions or worries
4.7 stars
Care provider's efforts to include you in decisions about your care
4.8 stars
Explanations the care provider gave you about your problem or condition
4.7 stars
Likelihood of recommending this care provider to others
4.7 stars
Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)
4.6 stars
Patient Comments
5.0 stars
Dr. Heatwole is amazing & has been a fabulous doctor during my visits. One of the best!
